ArticleStatistics in medicine2025
High-Dimensional Multiresponse Partially Functional Linear Regression.
Article in Statistics in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
We propose a new class of high-dimensional multiresponse partially functional linear regressions (MR-PFLRs) to investigate the relationship between scalar responses and a set of explanatory variables, which include both functional and scalar types. In this framework, both the dimensionality of the responses and the number of scalar covariates can diverge to infinity. To account for within-subject correlation, we develop a functional principal component analysis (FPCA)-based penalized weighted least squares estimation procedure. In this approach, the precision matrix is estimated using penalized likelihoods, and the regression coefficients are then estimated through the penalized weighted least squares method, with the precision matrix serving as the weight. This method allows for the simultaneous estimation of both functional and scalar regression coefficients, as well as the precision matrix, while identifying significant features. Under mild conditions, we establish the consistency, rates of convergence, and oracle properties of the proposed estimators. Simulation studies demonstrate the finite-sample performance of our estimation method. Additionally, the practical utility of the MR-PFLR model is showcased through an application to Alzheimer's disease neuroimaging initiative (ADNI) data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.